Related Experiment Videos
[Drug therapy of hypertrophic cardiomyopathy]
A Hartmann1, M Kaltenbach, R Hopf
1Abteilung für Kardiologie, Universität Frankfurt.
Insights
Hypertrophic cardiomyopathy (HCM) involves heart muscle thickening, potentially causing outflow obstruction. Medical treatments focus on improving relaxation and reducing the intraventricular gradient, with calcium antagonists being primary agents.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Medical Science
Context:
- Hypertrophic cardiomyopathy (HCM) is characterized by myocardial hypertrophy, which can lead to left ventricular outflow tract obstruction (HOCM).
- Left ventricular function in HCM exhibits hypercontractility and impaired diastolic relaxation.
Purpose:
- To outline the medical treatment strategies for hypertrophic cardiomyopathy (HCM).
- To discuss the role of pharmacological agents in managing HCM symptoms and complications.
Summary:
- Calcium antagonists are central to medical therapy for HCM, enhancing diastolic relaxation and reducing the intraventricular pressure gradient via negative inotropic effects.
- Beta-blockers can decrease the gradient in HOCM but do not improve relaxation.
- Diuretics, anti-arrhythmic drugs, and anticoagulants (e.g., marcumar for atrial fibrillation) may be used adjunctively.
- Prophylactic measures against endocarditis are recommended before dental or invasive procedures.
Impact:
- Provides a concise overview of current therapeutic approaches for HCM.
- Highlights the importance of tailored pharmacological interventions based on patient presentation.
- Emphasizes the need for endocarditis prophylaxis in patients with HCM undergoing specific procedures.
Introduction:
Hypertrophy of the myocardium occurring in hypertrophic cardiomyopathy (HCM) may affect different locations of the left ventricle. If the hypertrophy is sited in the region of the basal septum, obstruction of the left ventricular outflow tract (hypertrophic obstructive cardiomyopathy [HOCM]) occurs. characteristic of left ventricular function in HCM is hypercontractility and disordered diastolic relaxation.
Therapeutic Approaches:
In the medical treatment of HCM, the calcium antagonists play a leading role. They improve relaxation and, through their negative inotropic effect, decrease the intraventricular gradient. Although beta-blockers reduce the gradient in outflow tract obstruction, they do not improve relaxation. In individual cases the use of diuretics and anti-arrhythmic agents may be necessary; in the case of atrial fibrillation the use of marcumar is recommended.
Cautionary Remark:
In the event of dental treatment or invasive diagnostic procedures being necessary, prophylactic measures against endocarditis should be initiated.